Susan Desmond-Hellmann: Herceptin and Drug Development

Downloads in alternative formats: (To save, right click a link below and select "Save Target/Link As")
QuickTime (55.02mb) iPod/iPhone Video (60.04) View on YouTube

English Subtitles

About this talk
Desmond-Hellmann discusses the drug development process and shares her experience with the targeted cancer therapeutic, Herceptin.

About this speaker
An oncologist and leader in biotechnology, Susan Desmond-Hellmann is currently Chancellor of the University of California San Francisco. Prior to joining UCSF, Desmond-Hellmann spent 14 years at Genentech where she served as President, Product Development from 2004-2009. Under her direction, Genentech became the nation's No. 1 producer of anti-cancer drug treatments.

Connect to iBioSeminars
Full length seminars from leading
biologists >>

Subscribe
Receive our newsletter (every 2-3 months) announcing new talks on iBioMagazine. Subscribe >>